-
Innovation Ranking
NewInnovation Ranking – Electronic Arts Inc
Electronic Arts Inc (EA) is a provider of gaming software. It develops, markets, publishes and distributes digital interactive video games for electronic consoles and video game systems. Its video game software and content can be used on gaming consoles such as Microsoft Xbox, Apple App Store, Google Play store, Sony PlayStation and Nintendo WiiU. EA also develops gaming software for use on mobile devices, tablets, PCs and the internet. The company markets its games under its own brand names such...
-
Innovation Ranking
NewInnovation Ranking – Digital Arts Inc
Digital Arts Inc (Digital Arts) is a technology company that develops, sells and markets internet security software and appliances. The company provides products such as i-Filter for business, D-SPA, m-Filter, i-Filter browser and cloud, finalcode, ARS and i-Filter, among others. It offers services such as web filtering services, and encryption and data loss prevention, among others. Digital Arts' ARS and active rating system offers web filtering services. It offers services such as monitoring web access, controlling and securing outbound traffic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ART-27.13 in Cancer Anorexia-Cachexia Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-27.13 in Cancer Anorexia-Cachexia Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-27.13 in Cancer Anorexia-Cachexia Syndrome Drug Details: ART-27.13 (NEO-1940, AZD-1940) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ART-4215 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-4215 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-4215 in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Prostate Cancer Drug Details: ART-6043 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043 in Solid Tumor Drug Details: ART-6043 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-6043 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-6043 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-6043...
-
Product Insights
FAM/ NewVue Comm – Fitchburg Arts Community – Massachusetts
The FAM/ NewVue Comm – Fitchburg Arts Community – Massachusetts project involves the construction of affordable housing comprising 68 units in Fitchburg, Massachusetts, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our FAM/ NewVue Comm – Fitchburg Arts Community – Massachusetts report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays....
-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Sector Analysis
Assisted Reproductive Technology (ART) Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Assisted Reproductive Technology Devices Market Report Overview The global Assisted Reproductive Technology Devices market size was $282.9 million in 2023. Factors such as technical advances and the increasing geriatric population will drive the market growth at a CAGR of more than 4% from 2023 to 2033. Assisted reproductive technology (ART) refers to reproductive health procedures that help infertile women achieve pregnancy. These techniques primarily include in vitro fertilization (IVF), and intrauterine insemination (IUI). Both female and male infertility are epidemiological...